[1]杨　智　唐　栋　曹　磊　杨光诚.血清外泌体miRNA-30a-5p在人脑胶质瘤诊断及预后评价中的作用[J].中国临床神经外科杂志,2020,(05):296-298.[doi:10.13798/j.issn.1009-153X.2020.05.013]
　YANG Zhi,TANG Dong,CAO Lei,et al.Value of serum exosome miRNA-30a-5p to diagnosis and prognosis evaluation of human glioma[J].,2020,(05):296-298.[doi:10.13798/j.issn.1009-153X.2020.05.013]
点击复制

血清外泌体miRNA-30a-5p在人脑胶质瘤诊断及预后评价中的作用()

《中国临床神经外科杂志》[ISSN:1009-153X/CN:42-1603/TN]

卷:
期数:
2020年05期
页码:
296-298
栏目:
论著
出版日期:
2020-05-25

文章信息/Info

Title:
Value of serum exosome miRNA-30a-5p to diagnosis and prognosis evaluation of human glioma
文章编号:
1009-153X（2020）05-0296-03
作者:
杨　智　唐　栋　曹　磊　杨光诚
250022，济南市第五人民医院神经外科（杨　智、唐　栋、曹　磊、杨光诚）
Author(s):
YANG Zhi;  TANG Dong;  CAO Lei;  YANG Guang-cheng.
Department of Neurosurgery, The Fifth People's Hospital of Ji'nan City, Ji'nan 250022, China
关键词:
胶质瘤; 血清; 外泌体; miRNA-30a-5p; 诊断; 预后
Keywords:
Human glioma;  Serum;  Exosomes;  miRNA-30a-5p;  Diagnosis;  Prognosis
分类号:
R 739.41; Q 786
DOI:
10.13798/j.issn.1009-153X.2020.05.013
文献标志码:
A
摘要:
目的 探讨胶质瘤病人血清外泌体miRNA-30a-5p的表达水平，及其在胶质瘤诊断及预后评估中的价值。方法 选取2014年1月至2015年12月收治的胶质瘤60例为研究对象，另选取健康体检者40例为对照。RT-PCR检测血清外泌体miRNA-30a-5p表达水平。用受试者工作特性（ROC）曲线分析miRNA-30a-5p诊断胶质瘤的价值。用Kaplan-Meier法绘制生存曲线，采用log-rank检验；多因素Cox比例风险回归模型分析预后危险因素。结果 胶质瘤病人血清外泌体miRNA-30a-5p表达水平明显高于健康人（P<0.001）。ROC曲线分析显示，血清外泌体miRNA-30a-5p诊断胶质瘤的曲线下面积为0.901（95% CI 0.812~0.986），最佳截断值为0.601，此时miRNA-30a-5p诊断胶质瘤的灵敏度和特异度分别为78.05%和93.55%。术后60例均得到有效随访，随访时间平均（28.39±3.25）个月。Kaplan-Meier分析结果显示，血清外泌体miRNA-30a-5p低表达病人总体生存时间高于高表达病人（P<0.001）。多因素Cox比例回归风险模型分析结果显示血清外泌体miRNA-30a-5p高表达是胶质瘤病人不良预后的独立影响因素（P<0.05）。结论 血清外泌体miRNA-30a-5p对胶质瘤的诊断和预后评价均有一定价值
Abstract:
Objective To investigate the expression level of serum exosome miRNA-30a-5p in glioma patients and its value to the diagnosis and prognostic evaluation of glioma. Methods The expression of miRNA-30a-5p in exosomes was detected by RT-PCR in 60 glioma patients and 40 healthy people. Receiver operating characteristic (ROC) curve was used to analyze the value of miRNA-30a-5p to the diagnosis of gliomas. Kaplan-Meier method and log-rank test was used to analyze the overall survival time of the patients with glioma. Cox proportional risk model was used to analyze the prognostic factors of the patients with glioma. Results The expression level of serum exosome miRNA-30a-5p in glioma patients was significantly higher than that in healthy people (P<0.001). ROC curve analysis showed that the area under curve was 0.901 (95% CI 0.812~0.986), and the best cut-off value was 0.601. The sensitivity and specificity of serum exosome miRNA-30a-5p to the diagnosis of glioma was 78.05% and 93.55%, respectively. All these 60 glioma patients were followed up effectively after the operation, with an average follow-up time of (28.39±3.25) months. Kaplan-Meier analysis showed that the overall survival time of patients with low expression of serum exosome miRNA-30a-5p was significantly higher than that of patients with high expression of serum exosome miRNA-30a-5p (P<0.001). The results of multivariate Cox proportional regression risk model analysis showed that the high expression of serum exosome miRNA-30a-5p was an independent risk factor for the poor prognosis of glioma patients (P<0.05). Conclusion Serum exosome miRNA-30a-5p has certain value to the diagnosis and prognosis evaluation of human glioma

参考文献/References:

[1] Gusyatiner O, Hegi ME. Glioma epigenetics: From subcla- ssification to novel treatment options [J]. Semin Cancer Biol, 2018, 51(1): 50-58.
[2] Mansoori B, Mohammadi A, Shirjang S, et al. MicroRNAs in the diagnosis and treatment of cancer [J]. Immunol Invest, 2017, 46(8): 880-897.
[3] Yu X, Odenthal M, Fries JW. Exosomes as miRNA carriers: formation-function-future [J]. Int J Mol Sci, 2016, 17(12): E2028-E2037.
[5] 赵建辉，胡世颉，费　舟. miRNA在胶质瘤临床诊疗中的 研究进展 [J]. 中国临床神经外科杂志，2016，21（10）： 642-645.
[6] Wang Z, Dai X, Chen Y, et al. MiR-30a-5p is induced by Wnt/beta-catenin pathway and promotes glioma cell invasion by repressing NCAM [J]. Biochem Biophys Res Commun, 2015, 465(3): 374-380.
[7] Yang JK, Yang JP, Tong J, et al. Exosomal miR-221 targets DNM3 to induce tumor progression and temozolomide resistance in glioma [J]. J Neurooncol, 2016, 131(2): 1-11.
[8] Lan F, Qing Q, Pan Q, et al. Serum exosomal miR-301a as a potential diagnostic and prognostic biomarker for human glioma [J]. Cell Oncol (Dordr), 2018, 41(1): 25-33.

相似文献/References:

[1]刘青云　刘　俊　钟群琼　於　胜　隗世波.颅脑损伤患者血清甲状腺素和和肽素的变化[J].中国临床神经外科杂志,2017,(03):155.[doi:10.13798/j.issn.1009-153X.2017.03.009]
　Liu Qin-yun,LIU Jun,ZHONG Qun-qiong,et al.Changes in serum levels of thyroid hormones and copeptin in patients with severe traumatic brain injury[J].,2017,(05):155.[doi:10.13798/j.issn.1009-153X.2017.03.009]
[2]武元星　郝京京　王　强.血清及脑脊液降钙素原在神经外科术后颅内感染早期诊断中的应用[J].中国临床神经外科杂志,2017,(04):237.[doi:10.13798/j.issn.1009-153X.2017.04.010]
　WU Yuan-xing,HAO Jing-jing,WANG Qiang..Value of procalcitonin in serum and cerebrospinal fluid to diagnosis of intracranial infection early after craniotomy[J].,2017,(05):237.[doi:10.13798/j.issn.1009-153X.2017.04.010]
[3]杨文进　郭义君　童武松　郑　平　汪瑞忠　焦荣红　何　斌　陈　磊.急性颅脑损伤后早期血清Tau蛋白的动态变化及临床意义[J].中国临床神经外科杂志,2017,(08):536.[doi:10.13798/j.issn.1009-153X.2017.08.004]
　YANG Wen-jin,GUO Yi-jun,TONG Wu-song,et al.Dynamic change in serum level of tau protein and its clinical meanings in patients with acute traumatic brain injury[J].,2017,(05):536.[doi:10.13798/j.issn.1009-153X.2017.08.004]
[4]朱郭婷　陈思思　黄书岚.血清淀粉样蛋白A与自发性脑出血预后的关系[J].中国临床神经外科杂志,2017,(08):539.[doi:10.13798/j.issn.1009-153X.2017.08.005]
　ZHU Guo-ting,CHEN Si-si,HUANG Shu-lan..Relationship of serum level of amyloid protein A with prognoses in patients with acute spontaneous intracerebral hemorrhage[J].,2017,(05):539.[doi:10.13798/j.issn.1009-153X.2017.08.005]
[5]阮　东　王　芳　郭丽蕊　彭红梅　陈谦学　刘宝辉.C-反应蛋白与动脉瘤性蛛网膜下腔出血临床预后的关系[J].中国临床神经外科杂志,2017,(09):626.[doi:10.13798/j.issn.1009-153X.2017.09.006]
　RUAN Dong,WANG Fang,GUO Li-rui,et al.Relationship between serum level of C-reactive protein and prognoses in patients with aneurysmal subarachnoid hemorrhage[J].,2017,(05):626.[doi:10.13798/j.issn.1009-153X.2017.09.006]
[6]李建军.血清NSE与颅脑损伤术后早期颅内压增高-累计时间的相关性[J].中国临床神经外科杂志,2018,(02):78.
　LI Jian-jun..Correlativity of serum level of neuron specific enolase with pressure times time dose of intracranial pressure in patients with severe traumatic brain injury[J].,2018,(05):78.
[7]周建华　胡　涛　陈　宇　雷　丹　陈谦学.lncRNA NEAT1在人脑胶质瘤的表达变化及其与病人预后的关系[J].中国临床神经外科杂志,2019,(03):148.[doi:10.13798/j.issn.1009-153X.2019.03.007]
　ZHOU Jian- hua,HU Tao,CHEN Yu,et al.Relationship of expression level of long non-coding RNA NEAT1 with prognoses in the patients with gliomas[J].,2019,(05):148.[doi:10.13798/j.issn.1009-153X.2019.03.007]
[8]刘骏辉　许鹏飞　杨吉安　高　论 综述　陈谦学 审校.儿童脑桥弥漫内生型胶质瘤的研究进展[J].中国临床神经外科杂志,2019,(03):178.[doi:10.13798/j.issn.1009-153X.2019.03.019]
[9]孙瑞迅　李琳坤　董　辉　刘　飒.脑胶质瘤病人SII、血清Fib和AGR水平变化及意义[J].中国临床神经外科杂志,2020,(04):209.[doi:10.13798/j.issn.1009-153X.2020.04.006]
　SUN Rui-xun,LI Lin-kun,DONG Hui,et al.Changes of SII, serum levels of Fib and AGR and their clinical significances in patients with gliomas[J].,2020,(05):209.[doi:10.13798/j.issn.1009-153X.2020.04.006]
[10]王　阳　平建峰　刘会星.缺血性脑卒中后认知功能障碍病人血清胱抑素-C水平变化及其意义[J].中国临床神经外科杂志,2020,(04):212.[doi:10.13798/j.issn.1009-153X.2020.04.007]
　WANG Yang,PING Jian-feng,LIU Hui-xing..Change of serum level of cystatin C and its meanings in patients with cognitive dysfunction after ischemic stroke[J].,2020,(05):212.[doi:10.13798/j.issn.1009-153X.2020.04.007]

备注/Memo

备注/Memo:
（2019-12-27收稿，2020-03-02修回）
更新日期/Last Update: 1900-01-01